Facilitation of drug transport across the blood–brain barrier with ultrasound and microbubbles

Pharmaceutics

Volumn 7, Issue 3, 2015, Pages 275-293

  Meairs, Stephen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Blood brain barrier; CNS disease; Focused ultrasound; Microbubbles; Safety

Indexed keywords

4 BORONOPHENYLALANINE; BETA GALACTOSIDASE; CARMUSTINE; CYTARABINE; DOXORUBICIN; GADOLINIUM PENTETATE; INTERLEUKIN 12; LIPOSOME; METHOTREXATE; PERFLUTREN; PLASMID DNA; SHU 508; TEMOZOLOMIDE; TRASTUZUMAB;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION; DNA TRANSFECTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TRANSPORT; ENDOCYTOSIS; FOCUSED ULTRASOUND; GENE THERAPY; GLIOMA; HUMAN; KINETICS; MICROBUBBLE; MORPHOLOGY; NEUTRON CAPTURE THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SAFETY; ULTRASOUND;

EID: 84940726416     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics7030275     Document Type: Review

References (89)

1. Pardridge, W.M. The blood-brain barrier: Bottleneck in brain drug development. NeuroRx. 2005, 2, 3-14.
2. Angelov, L.; Doolittle, N.D.; Kraemer, D.F.; Siegal, T.; Barnett, G.H.; Peereboom, D.M.; Stevens, G.; McGregor, J.; Jahnke, K.; Lacy, C.A.; et al. Blood-brain barrier disruption and intraarterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: A multiinstitutional experience. J. Clin. Oncol. 2009, 27, 3503-3509.
3. Jahnke, K.; Kraemer, D.F.; Knight, K.R.; Fortin, D.; Bell, S.; Doolittle, N.D.; Muldoon, L.L.; Neuwelt, E.A. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system. Cancer 2008, 112, 581-588.
4. Guillaume, D.J.; Doolittle, N.D.; Gahramanov, S.; Hedrick, N.A.; Delashaw, J.B.; Neuwelt, E.A. Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: Results of a phase I study. Neurosurgery 2010, 66, 48-58.
5. Boado, R.J.; Hui, E.K.; Lu, J.Z.; Pardridge, W.M. Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horse. J. Pharmacol. Exp. Ther. 2010, 333, 961-969.
6. Boado, R.J.; Hui, E.K.; Lu, J.Z.; Zhou, Q.H.; Pardridge, W.M. Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein. J. Biotechnol. 2010, 146, 84-91.
7. Gaillard, P.J.; Visser, C.C.; de Boer, A.G. Targeted delivery across the blood-brain barrier. Exp. Opin. Drug Deliv. 2005, 2, 299-309.
8. Kurakhmaeva, K.B.; Djindjikhashvili, I.A.; Petrov, V.E.; Balabanyan, V.U.; Voronina, T.A.; Trofimov, S.S.; Kreuter, J.; Gelperina, S.; Begley, D.; Alyautdin, R.N. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles. J. Drug Target. 2009, 17, 564-574.
9. Fung, L.K.; Shin, M.; Tyler, B.; Brem, H.; Saltzman, W.M. Chemotherapeutic drugs released from polymers: Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. Pharm. Res. 1996, 13, 671-682.
10. Fleischhack, G.; Jaehde, U.; Bode, U. Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis. Clin. Pharmacokinet. 2005, 44, 1-31.
11. Groothuis, D.R. The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery. Neuro. Oncol. 2000, 2, 45-59.
12. Illum, L. Nasal drug delivery-Possibilities, problems and solutions. J. Control. Release 2003, 87, 187-198.
13. Illum, L. Nasal drug delivery-Recent developments and future prospects. J. Control. Release 2012, 161, 254-263.
14. Pires, A; Fortuna, A.; Alves, G.; Falcao, A. Intranasal drug delivery: How, why and what for? J. Pharm. Pharm. Sci. 2009, 12, 288-311.
15. Abbott, N.J.; Friedman, A. Overview and introduction: The blood-brain barrier in health and disease. Epilepsia 2012, 53, 1-6.
16. Petty, M.A.; Lo, E.H. Junctional complexes of the blood-brain barrier: Permeability changes in neuroinflammation. Prog. Neurobiol. 2002, 68, 311-323.
17. Kirk, J.; Plumb, J.; Mirakhur, M.; McQuaid, S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J. Pathol. 2003, 201, 319-327.
18. Dallasta, L.M.; Pisarov, L.A.; Esplen, J.E.; Werley, J.V.; Moses, A.V.; Nelson, J.A.; Achim, C.L. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J. Pathol. 1999, 155, 1915-1927.
19. Hawkins, B.T.; Davis, T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 2005, 57, 173-185.
20. Wardlaw, J.M.; Sandercock, P.A.; Dennis, M.S.; Starr, J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003, 34, 806-812.
21. Erickson, M.A.; Banks, W.A. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J. Cereb. Blood Flow Metab. 2013, 33, 1500-1513.
22. Hynynen, K.; McDannold, N.; Vykhodtseva, N.; Jolesz, F.A. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001, 220, 640-646.
23. Kinoshita, M.; McDannold, N.; Jolesz, F.A.; Hynynen, K. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem. Biophys. Res. Commun. 2006, 340, 1085-1090.
24. McDannold, N.; Vykhodtseva, N.; Hynynen, K. Targeted disruption of the blood-brain barrier with focused ultrasound: Association with cavitation activity. Phys. Med. Biol. 2006, 51, 793-807.
25. McDannold, N.; Vykhodtseva, N.; Raymond, S.; Jolesz, F.A.; Hynynen, K. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: Histological findings in rabbits. Ultrasound Med. Biol. 2005, 31, 1527-1537.
26. Mesiwala, A.H.; Farrell, L.; Wenzel, H.J.; Silbergeld, D.L.; Crum, L.A.; Winn, H.R.; Mourad, P.D. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med. Biol. 2002, 28, 389-400.
27. Chu, P.C.; Chai, W.Y.; Hsieh, H.Y.; Wang, J.J.; Wey, S.P.; Huang, C.Y.; Wei, K.C.; Liu, H.L. Pharmacodynamic analysis of magnetic resonance imaging-monitored focused ultrasound-induced blood-brain barrier opening for drug delivery to brain tumors. Biomed. Res. Int. 2013, 2013, 627496.
28. Lammers, T.; Koczera, P.; Fokong, S.; Gremse, F.; Ehling, J.; Vogt, M.; Pich, A.; Storm, G.; van Zandvoort, M.; Kiessling, F. Theranostic USPIO-Loaded Microbubbles for Mediating and Monitoring Blood-Brain Barrier Permeation. Adv. Funct. Mater. 2015, 25, 36-43.
29. Shi, L.; Palacio-Mancheno, P.; Badami, J.; Shin, D.W.; Zeng, M.; Cardoso, L.; Tu, R.; Fu, B.M. Quantification of transient increase of the blood-brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles. Int. J. Nanomed. 2014, 9, 4437-4448.
30. Nhan, T.; Burgess, A.; Cho, E.E.; Stefanovic, B.; Lilge, L.; Hynynen, K. Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: Quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy. J. Control. Release 2013, 172, 274-280.
31. Burgess, A.; Nhan, T.; Moffatt, C.; Klibanov, A.L.; Hynynen, K. Analysis of focused ultrasoundinduced blood-brain barrier permeability in a mouse model of Alzheimer's disease using twophoton microscopy. J. Control. Release 2014, 192, 243-248.
32. Fry, W.; Fry, F. Fundamental neurological research and human neurosurgery using intense ultrasound. IRE. Trans. Med. Electron. 1960, ME-7, 166-181.
33. Tanter, M.; Aubry, J.F.; Gerber, J.; Thomas, J.L.; Fink, M. Optimal focusing by spatio-temporal inverse filter. I. Basic principles. J. Acoust. Soc. Am. 2001, 110, 37-47.
34. Aubry, J.F.; Tanter, M.; Gerber, J.; Thomas, J.L.; Fink, M. Optimal focusing by spatio-temporal inverse filter. II. Experiments. Application to focusing through absorbing and reverberating media. J. Acoust. Soc. Am. 2001, 110, 48-58.
35. Hynynen, K.; McDannold, N. MRI guided and monitored focused ultrasound thermal ablation methods: A review of progress. Int. J. Hyperthermia. 2004, 20, 725-737.
36. Aubry, J.F.; Tanter, M.; Pernot, M.; Thomas, J.L.; Fink, M. Experimental demonstration of noninvasive transskull adaptive focusing based on prior computed tomography scans. J. Acoust. Soc. Am. 2003, 113, 84-93.
37. Marquet, F.; Pernot, M.; Aubry, J.F.; Montaldo, G.; Marsac, L.; Tanter, M.; Fink, M. Noninvasive transcranial ultrasound therapy based on a 3D CT scan: Protocol validation and in vitro results. Phys. Med. Biol. 2009, 54, 2597-2613.
38. Clement, G.T.; Hynynen, K. A non-invasive method for focusing ultrasound through the human skull. Phys. Med. Biol. 2002, 47, 1219-1236.
39. Ishihara, Y.; Calderon, A.; Watanabe, H.; Okamoto, K.; Suzuki, Y.; Kuroda, K.; Suzuki, Y. A precise and fast temperature mapping using water proton chemical shift. Magn Reson. Med. 1995, 34, 814-823.
40. McDannold, N.; Clement, G.T.; Black, P.; Jolesz, F.; Hynynen, K. Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurgery. 2010, 66, 323-332.
41. Elias, W.J.; Huss, D.; Voss, T.; Loomba, J.; Khaled, M.; Zadicario, E.; Frysinger, R.C.; Sperling, S.A.; Wylie, S.; Monteith, S.J.; et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N. Engl. J. Med. 2013, 369, 640-648.
42. Taniyama, Y.; Tachibana, K.; Hiraoka, K.; Namba, T.; Yamasaki, K.; Hashiya, N.; Aoki, M.; Ogihara, T.; Yasufumi, K.; Morishita, R. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002, 105, 1233-1239.
43. Ogawa, K.; Tachibana, K.; Uchida, T.; Tai, T.; Yamashita, N.; Tsujita, N.; Miyauchi, R. High-resolution scanning electron microscopic evaluation of cell-membrane porosity by ultrasound. Med. Electron Microsc. 2001, 34, 249-253.
44. Sheikov, N.; McDannold, N.; Vykhodtseva, N.; Jolesz, F.; Hynynen, K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med. Biol. 2004, 30, 979-989.
45. Sheikov, N.; McDannold, N.; Sharma, S.; Hynynen, K. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med. Biol. 2008, 34, 1093-1104.
46. Chen, P.Y.; Hsieh, H.Y.; Huang, C.Y.; Lin, C.Y.; Wei, K.C.; Liu, H.L. Focused ultrasoundinduced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: A preclinical feasibility study. J. Transl. Med. 2015, 13, 451.
47. Marty, B.; Larrat, B.; van Landeghem, M.; Robic, C.; Robert, P.; Port, M.; Le, B.D.; Pernot, M.; Tanter, M.; Lethimonnier, F.; et al. Dynamic study of blood-brain barrier closure after its disruption using ultrasound: A quantitative analysis. J. Cereb. Blood Flow Metab. 2012, 32, 1948-1958.
48. Hynynen, K.; McDannold, N.; Sheikov, N.A.; Jolesz, F.A.; Vykhodtseva, N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for transskull sonications. Neuroimage 2005, 24, 12-20.
49. Hynynen, K.; McDannold, N.; Martin, H.; Jolesz, F.A.; Vykhodtseva, N. The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison). Ultrasound Med. Biol. 2003, 29, 473-481.
50. Schlachetzki, F.; Holscher, T.; Koch, H.J.; Draganski, B.; May, A.; Schuierer, G.; Bogdahn, U. Observation on the integrity of the blood-brain barrier after microbubble destruction by diagnostic transcranial color-coded sonography. J. Ultrasound Med. 2002, 21, 419-429.
51. Alonso, A.; Reinz, E.; Jenne, J.W.; Fatar, M.; Schmidt-Glenewinkel, H.; Hennerici, M.G.; Meairs, S. Reorganization of gap junctions after focused ultrasound blood-brain barrier opening in the rat brain. J. Cereb. Blood Flow Metab. 2010, 30, 1394-1402.
52. Alonso, A; Reinz, E.; Fatar, M.; Jenne, J.; Hennerici, M.G.; Meairs, S. Neurons but not glial cells overexpress ubiquitin in the rat brain following focused ultrasound-induced opening of the bloodbrain barrier. Neuroscience 2010, 169, 116-124.
53. Alonso, A.; Reinz, E.; Fatar, M.; Hennerici, M.G.; Meairs, S. Clearance of albumin following ultrasound-induced blood-brain barrier opening is mediated by glial but not neuronal cells. Brain Res. 2011, 1411, 9-16.
54. Tung, Y.S.; Marquet, F.; Teichert, T.; Ferrera, V.; Konofagou, E.E. Feasibility of noninvasive cavitation-guided blood-brain barrier opening using focused ultrasound and microbubbles in nonhuman primates. Appl. Phys. Lett. 2011, 98, 163704.
55. Arvanitis, C.D.; Livingstone, M.S.; Vykhodtseva, N.; McDannold, N. Controlled ultrasoundinduced blood-brain barrier disruption using passive acoustic emissions monitoring. PLoS ONE 2012, 7, e45783.
56. McDannold, N.; Arvanitis, C.D.; Vykhodtseva, N.; Livingstone, M.S. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: Safety and efficacy evaluation in rhesus macaques. Cancer Res. 2012, 72, 3652-3663.
57. Treat, L.H.; McDannold, N.; Vykhodtseva, N.; Zhang, Y.; Tam, K.; Hynynen, K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int. J Cancer. 2007, 121, 901-907.
58. Park, J.; Zhang, Y.; Vykhodtseva, N.; Jolesz, F.A.; McDannold, N.J. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound. J. Control. Release 2012, 162, 134-142.
59. Liu, H.L.; Hua, M.Y.; Chen, P.Y.; Chu, P.C.; Pan, C.H.; Yang, H.W.; Huang, C.Y.; Wang, J.J.; Yen, T.C.; Wei, K.C. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 2010, 255, 415-425.
60. Mei, J.; Cheng, Y.; Song, Y.; Yang, Y.; Wang, F.; Liu, Y.; Wang, Z. Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound. J. Ultrasound Med. 2009, 28, 871-880.
61. Zeng, H.Q.; Lu, L.; Wang, F.; Luo, Y.; Lou, S.F. Focused ultrasound-induced blood-brain barrier disruption enhances the delivery of cytarabine to the rat brain. J. Chemother. 2012, 24, 358-363.
62. Wei, K.C.; Chu, P.C.; Wang, H.Y.; Huang, C.Y.; Chen, P.Y.; Tsai, H.C.; Lu, Y.J.; Lee, P.Y.; Tseng, I.C.; Feng, L.Y.; et al. Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: A preclinical study. PLoS ONE 2013, 8, e58995.
63. Aryal, M.; Vykhodtseva, N.; Zhang, Y.Z.; Park, J.; McDannold, N. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J. Control. Release 2013, 169, 103-111.
64. Yang, F.Y.; Wong, T.T.; Teng, M.C.; Liu, R.S.; Lu, M.; Liang, H.F.; Wei, M.C. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J. Control. Release 2012, 160, 652-658.
65. Fan, C.H.; Ting, C.Y.; Lin, H.J.; Wang, C.H.; Liu, H.L.; Yen, T.C.; Yeh, C.K. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced braintumor drug delivery. Biomaterials 2013, 34, 3706-3715.
66. Lin, C.Y.; Hsieh, H.Y.; Pitt, W.G.; Huang, C.Y.; Tseng, I.C.; Yeh, C.K.; Wei, K.C.; Liu, H.L. Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery. J. Control. Release 2015, 212, 1-9.
67. Burgess, A.; Ayala-Grosso, C.A.; Ganguly, M.; Jordao, J.F.; Aubert, I.; Hynynen, K. Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier. PLoS ONE 2011, 6, e27877.
68. Burgess, A.; Huang, Y.; Querbes, W.; Sah, D.W.; Hynynen, K. Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression. J. Control. Release 2012, 163, 125-129.
69. Unger, E.C.; Hersh, E.; Vannan, M.; Matsunaga, T.O.; McCreery, T. Local drug and gene delivery through microbubbles. Prog. Cardiovasc. Dis. 2001, 44, 45-54.
70. Fischer, A.J.; Stanke, J.J.; Omar, G.; Askwith, C.C.; Burry, R.W. Ultrasound-mediated gene transfer into neuronal cells. J. Biotechnol. 2006, 122, 393-411.
71. Alonso, A.; Reinz, E.; Leuchs, B.; Kleinschmidt, J.; Fatar, M.; Geers, B.; Lentacker, I.; Hennerici, M.G.; De Smedt, S.C.; Meairs, S. Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening. Mol. Ther. Nucleic Acids 2013, 2, e73.
72. Wang, S.; Olumolade, O.O.; Sun, T.; Samiotaki, G.; Konofagou, E.E. Noninvasive, neuronspecific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus. Gene Ther. 2015, 22, 104-110.
73. Shohet, R.V.; Chen, S.; Zhou, Y.T.; Wang, Z.; Meidell, R.S.; Unger, R.H.; Grayburn, P.A. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000, 101, 2554-2556.
74. Ting, C.Y.; Fan, C.H.; Liu, H.L.; Huang, C.Y.; Hsieh, H.Y.; Yen, T.C.; Wei, K.C.; Yeh, C.K. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials 2012, 33, 704-712.
75. Fan, C.H.; Ting, C.Y.; Liu, H.L.; Huang, C.Y.; Hsieh, H.Y.; Yen, T.C.; Wei, K.C.; Yeh, C.K. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment. Biomaterials 2013, 34, 2142-2155.
76. Xi, X.; Yang, F.; Chen, D.; Luo, Y.; Zhang, D.; Gu, N.; Wu, J. A targeting drug-delivery model via interactions among cells and liposomes under ultrasonic excitation. Phys. Med. Biol. 2008, 53, 3251-3265.
77. Vandenbroucke, R.E.; Lentacker, I.; Demeester, J.; De Smedt, S.C.; Sanders, N.N. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles. J Control. Release 2008, 126, 265-273.
78. Geers, B; Lentacker, I.; Sanders, N.N.; Demeester, J.; Meairs, S.; De Smedt, S.C. Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drugdelivery. J. Control. Release 2011, 152, 249-256.
79. Kinoshita, M.; McDannold, N.; Jolesz, F.A.; Hynynen, K. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc. Natl. Acad. Sci. USA 2006, 103, 11719-11723.
80. Park, E.J.; Zhang, Y.Z.; Vykhodtseva, N.; McDannold, N. Ultrasound-mediated bloodbrain/ blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J. Control. Release 2012, 163, 277-284.
81. Alkins, R.D.; Brodersen, P.M.; Sodhi, R.N.; Hynynen, K. Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound. Neuro. Oncol. 2013, 15, 1225-1235.
82. Yang, F.Y.; Chen, Y.W.; Chou, F.I.; Yen, S.H.; Lin, Y.L.; Wong, T.T. Boron neutron capture therapy for glioblastoma multiforme: Enhanced drug delivery and antitumor effect following blood-brain barrier disruption induced by focused ultrasound. Future Oncol. 2012, 8, 1361-1369.
83. Alkins, R.; Burgess, A.; Ganguly, M.; Francia, G.; Kerbel, R.; Wels, W.S.; Hynynen, K. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res. 2013, 73, 1892-1899.
84. Aryal, M.; Park, J.; Vykhodtseva, N.; Zhang, Y.Z.; McDannold, N. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: Evaluation during tumor progression in a rat glioma model. Phys. Med. Biol. 2015, 60, 2511-2527.
85. Beccaria, K.; Canney, M.; Goldwirt, L.; Fernandez, C.; Adam, C.; Piquet, J.; Autret, G.; Clement, O.; Lafon, C.; Chapelon, J.Y.; et al. Opening of the blood-brain barrier with an unfocused ultrasound device in rabbits. J. Neurosurg. 2013, 119, 887-898.
86. Jordao, J.F.; Ayala-Grosso, C.A.; Markham, K.; Huang, Y.; Chopra, R.; McLaurin, J.; Hynynen, K.; Aubert, I. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease. PLoS ONE 2010, 5, e10549.
87. Jordao, J.F.; Thevenot, E.; Markham-Coultes, K.; Scarcelli, T.; Weng, Y.Q.; Xhima, K.; O'Reilly, M.; Huang, Y.; McLaurin, J.; Hynynen, K.; et al. Amyloid-beta plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp. Neurol. 2013, 248, 16-29.
88. Burgess, A.; Dubey, S.; Yeung, S.; Hough, O.; Eterman, N.; Aubert, I.; Hynynen, K. Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior. Radiology 2014, 273, 736-745.
89. Leinenga, G.; Gotz, J. Scanning ultrasound removes amyloid-beta and restores memory in an Alzheimer's disease mouse model. Sci. Transl. Med. 2015, 7, 278ra33.